• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    Novavax, Inc. (NVAX)

    -NasdaqGS
    10.88 Down 0.12(1.09%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:11.00
    Open:11.04
    Bid:10.55 x 1000
    Ask:11.85 x 100
    1y Target Est:11.16
    Beta:1.26
    Earnings Date:Aug 4 - Aug 10 (Est.)
    Day's Range:10.77 - 11.07
    52wk Range:3.92 - 11.45
    Volume:2,086,217
    Avg Vol (3m):3,281,230
    Market Cap:2.92B
    P/E (ttm):N/A
    EPS (ttm):-0.40
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NVAXDown 1.09%2.92B
    MRKUp 0.12%162.93B
    NVSUp 1.30%241.55B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):89.10
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.41
    Quarterly EPS Est (Jun-15) :-0.09
    Mean Recommendation*:1.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback